Involvement of Integrin Alpha(v)beta(3) and Cell Adhesion Molecule L1 in Transendothelial Migration of Melanoma Cells

Overview

Journal Mol Biol Cell

Specialties Cell Biology
Molecular Biology

Date 2001 Sep 13

PMID 11553709

Citations 73

Authors

E B Voura

R A Ramjeesingh

A M Montgomery

C H Siu

Affiliations

Soon will be listed here.

Abstract

Tumor metastasis involves many stage-specific adhesive interactions. The expression of several cell adhesion molecules, notably the integrin alpha(v)beta(3), has been associated with the metastatic potential of tumor cells. In this study, we used a novel in vitro assay to examine the role of alpha(v)beta(3) in the transmigration of melanoma cells through a monolayer of human lung microvascular endothelial cells. Confocal microscopy revealed the presence of the integrin alpha(v)beta(3) on melanoma membrane protrusions and pseudopods penetrating the endothelial junction. alpha(v)beta(3) was also enriched in heterotypic contacts between endothelial cells and melanoma cells. Transendothelial migration of melanoma cells was inhibited by either a cyclic Arg-Gly-Asp peptide or the anti-alpha(v)beta(3) monoclonal antibody LM609. Although both platelet endothelial cell adhesion molecule-1 and L1 are known to bind integrin alpha(v)beta(3), only L1 serves as a potential ligand for alpha(v)beta(3) during melanoma transendothelial migration. Also, polyclonal antibodies against L1 partially inhibited the transendothelial migration of melanoma cells. However, addition of both L1 and alpha(v)beta(3) antibodies did not show additive effects, suggesting that they are components of the same adhesion system. Together, the data suggest that interactions between the integrin alpha(v)beta(3) on melanoma cells and L1 on endothelial cells play an important role in the transendothelial migration of melanoma cells.

Citing Articles

The impact of platelets on the metastatic potential of tumour cells.

Raskov H, Orhan A, Agerbaek M, Gogenur I Heliyon. 2024; 10(14):e34361.

PMID: 39114075 PMC: 11305202. DOI: 10.1016/j.heliyon.2024.e34361.

Interaction of Drug-Sensitive and -Resistant Human Melanoma Cells with HUVEC Cells: A Label-Free Cell-Based Impedance Study.

Bozzuto G, Colone M, Toccacieli L, Molinari A, Calcabrini A, Stringaro A Biomedicines. 2023; 11(6).

PMID: 37371639 PMC: 10294930. DOI: 10.3390/biomedicines11061544.

Role of the Hedgehog Pathway and CAXII in Controlling Melanoma Cell Migration and Invasion in Hypoxia.

Giuntini G, Coppola F, Falsini A, Filippi I, Monaci S, Naldini A Cancers (Basel). 2022; 14(19).

PMID: 36230699 PMC: 9563772. DOI: 10.3390/cancers14194776.

Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis.

Bai S, Wang Z, Wang M, Li J, Wei Y, Xu R Front Cell Dev Biol. 2022; 10:752818.

PMID: 35309949 PMC: 8924426. DOI: 10.3389/fcell.2022.752818.

Rethinking the biology of metastatic melanoma: a holistic approach.

Vandyck H, Hillen L, Bosisio F, van den Oord J, Zur Hausen A, Winnepenninckx V Cancer Metastasis Rev. 2021; 40(2):603-624.

PMID: 33870460 PMC: 8213587. DOI: 10.1007/s10555-021-09960-8.

References

Lafrenie R, Gallo S, Podor T, Buchanan M, Orr F . The relative roles of vitronectin receptor, E-selectin and alpha 4 beta 1 in cancer cell adhesion to interleukin-1-treated endothelial cells. Eur J Cancer. 1994; 30A(14):2151-8. DOI: 10.1016/0959-8049(94)00354-8. View

Strongin A, Collier I, Bannikov G, Marmer B, Grant G, Goldberg G . Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem. 1995; 270(10):5331-8. DOI: 10.1074/jbc.270.10.5331. View

Muller W . The role of PECAM-1 (CD31) in leukocyte emigration: studies in vitro and in vivo. J Leukoc Biol. 1995; 57(4):523-8. DOI: 10.1002/jlb.57.4.523. View

Piali L, Hammel P, Uherek C, Bachmann F, Gisler R, Dunon D . CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol. 1995; 130(2):451-60. PMC: 2199946. DOI: 10.1083/jcb.130.2.451. View

Reid R, Hemperly J . Variants of human L1 cell adhesion molecule arise through alternate splicing of RNA. J Mol Neurosci. 1992; 3(3):127-35. DOI: 10.1007/BF02919404. View

Horstkorte R, Schachner M, Magyar J, Vorherr T, Schmitz B . The fourth immunoglobulin-like domain of NCAM contains a carbohydrate recognition domain for oligomannosidic glycans implicated in association with L1 and neurite outgrowth. J Cell Biol. 1993; 121(6):1409-21. PMC: 2119715. DOI: 10.1083/jcb.121.6.1409. View

Muller W, Weigl S, Deng X, Phillips D . PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med. 1993; 178(2):449-60. PMC: 2191108. DOI: 10.1084/jem.178.2.449. View

Stetler-Stevenson W, Aznavoorian S, Liotta L . Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol. 1993; 9:541-73. DOI: 10.1146/annurev.cb.09.110193.002545. View

Kujat R, Miragall F, Krause D, Dermietzel R, Wrobel K . Immunolocalization of the neural cell adhesion molecule L1 in non-proliferating epithelial cells of the male urogenital tract. Histochem Cell Biol. 1995; 103(4):311-21. DOI: 10.1007/BF01457416. View

10.

Zhao X, Siu C . Colocalization of the homophilic binding site and the neuritogenic activity of the cell adhesion molecule L1 to its second Ig-like domain. J Biol Chem. 1995; 270(49):29413-21. DOI: 10.1074/jbc.270.49.29413. View

11.

Ruppert M, Aigner S, Hubbe M, Yagita H, Altevogt P . The L1 adhesion molecule is a cellular ligand for VLA-5. J Cell Biol. 1995; 131(6 Pt 2):1881-91. PMC: 2120661. DOI: 10.1083/jcb.131.6.1881. View

12.

Izumoto S, Ohnishi T, Arita N, Hiraga S, Taki T, Hayakawa T . Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion. Cancer Res. 1996; 56(6):1440-4. View

13.

Orr F, Wang H, Lafrenie R, Scherbarth S, Nance D . Interactions between cancer cells and the endothelium in metastasis. J Pathol. 2000; 190(3):310-29. DOI: 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P. View

14.

Johnson J . Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev. 2000; 18(3):345-57. DOI: 10.1023/a:1006304806799. View

15.

Deryugina E, Bourdon M, Jungwirth K, Smith J, Strongin A . Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int J Cancer. 2000; 86(1):15-23. DOI: 10.1002/(sici)1097-0215(20000401)86:1<15::aid-ijc3>3.0.co;2-b. View

16.

Hofmann U, Westphal J, van Kraats A, Ruiter D, van Muijen G . Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo. Int J Cancer. 2000; 87(1):12-9. DOI: 10.1002/1097-0215(20000701)87:1<12::aid-ijc3>3.0.co;2-a. View

17.

Kumar C, Armstrong L, Yin Z, Malkowski M, Maxwell E, Ling H . Targeting integrins alpha v beta 3 and alpha v beta 5 for blocking tumor-induced angiogenesis. Adv Exp Med Biol. 2000; 476:169-80. View

18.

Kim S, Harris M, Varner J . Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A. J Biol Chem. 2000; 275(43):33920-8. DOI: 10.1074/jbc.M003668200. View

19.

Silletti S, Kessler T, Goldberg J, Boger D, Cheresh D . Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc Natl Acad Sci U S A. 2001; 98(1):119-24. PMC: 14554. DOI: 10.1073/pnas.98.1.119. View

20.

Deryugina E, Ratnikov B, Monosov E, Postnova T, DiScipio R, Smith J . MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res. 2001; 263(2):209-23. DOI: 10.1006/excr.2000.5118. View